Convener: Reuven Behar, Partner, Fischer Behar Chen Well Orion & Co.
Monday, April 30, 3:00 pm- 4:30 pm
Charging excessive prices for products protected by patents is a source of controversy and occasionally comes up, in particular, although not only in the field of pharmaceuticals. The Israeli Restrictive Trade Practices Law provides that establishing “unfair prices” by a monopoly may be deemed as abuse of a dominant position. In a 2015 case, the Central District Court ruled that prosecuting a patent application that was eventually abandoned amounts to abuse of a dominant position and the defendant (Sanofi) was ordered to pay a percentage of its profit to the plaintiff (Unipharm). Royalties paid to societies for intellectual property rights have also been under scrutiny, both in Israel and worldwide. These and other issues will be covered in the session.
- Justice Prof. Ofer Grosskopf, Supreme Court
- Judge (retired) Dr. Iris Soroker, The head of the Heth Academic Center for Research of Competition and Regulation, of the College of Management.
- Thomas Vinje, Partner, Chairman, Global Antitrust Group, Clifford Chance, Brussels
- Adv. Liad Whatstein, Founding Partner, Liad Whatstein & Co.
- Shlomi Parizat, Chairman of Finance Committee, Shenkar – Engineering. Design. Art. and Dean’s Fellow, Recanati Business School, The Hebrew University.